4,678
Views
17
CrossRef citations to date
0
Altmetric
Research Articles

Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2

, , , , , , , , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 6290-6305 | Received 16 Jun 2020, Accepted 13 Jul 2020, Published online: 28 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shaila Akter, Md. Jahirul Islam, Md. Ackas Ali, Md. Zakaria Tashrif, Md. Jaish Uddin, M. Obayed Ullah & Mohammad A. Halim. (2023) Structure and dynamics of whole-sequence homology model of ORF3a protein of SARS-CoV-2: An insight from microsecond molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Alexandre de Fátima Cobre, Moisés Maia Neto, Eduardo Borges de Melo, Mariana Millan Fachi, Luana Mota Ferreira, Fernanda Stumpf Tonin & Roberto Pontarolo. (2023) Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Rumana Mahtarin, Shafiqul Islam, Md. Jahirul Islam, M Obayed Ullah, Md Ackas Ali & Mohammad A. Halim. (2022) Structure and dynamics of membrane protein in SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 40:10, pages 4725-4738.
Read now

Articles from other publishers (14)

Yang Hu, Xu Zhang, Li‐peng Shan, Lei Liu & Jiong Chen. (2023) The antiviral activity of currently used medicinal plants in aquaculture and structure–activity relationship of their active ingredients. Reviews in Aquaculture.
Crossref
Debanjan Mitra, Shagufta Afreen, Pradeep K. Das Mohapatra & Mohnad Abdalla. (2023) Threat of respiratory syncytial virus infection knocking the door: a proposed potential drug candidate through molecular dynamics simulations, a future alternative. Journal of Molecular Modeling 29:4.
Crossref
Sneha Bansode, Pawan Kumar Singh, Meenakshi Tellis, Anita Chugh, Narendra Deshmukh, Mahesh Gupta, Savita Verma, Ashok Giri, Mahesh Kulkarni, Rakesh Joshi & Dhruva Chaudhary. (2023) A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine. Vaccines 11:3, pages 515.
Crossref
Iktedar Mahdi, Humyara Yeasmin, Imtiaz Hossain, Raina Masnoon Badhan, Md. Ackas Ali, Md. Abdul Kaium, Rajib Islam, Md. Abu Sufian & Mohammad A. Halim. (2022) Potential antiviral peptides against the nucleoprotein of SARS-CoV-2. Chemical Papers 77:2, pages 813-823.
Crossref
Dylan Brunt, Phillip M. Lakernick & Chun Wu. (2022) Discovering new potential inhibitors to SARS-CoV-2 RNA dependent RNA polymerase (RdRp) using high throughput virtual screening and molecular dynamics simulations. Scientific Reports 12:1.
Crossref
Sarah Mousavi, Shima Zare, Mahmoud Mirzaei & Awat Feizi. (2022) Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies. Canadian Journal of Infectious Diseases and Medical Microbiology 2022, pages 1-70.
Crossref
Sheeba Saifi, Varsha Ravi, Sparsh Sharma, Aparna Swaminathan, Nar Singh Chauhan & Rajesh Pandey. (2022) SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: Are they modulating drug efficacy by altered binding strength?. Genomics 114:5, pages 110466.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Iart Luca Shytaj, Mohamed Fares, Lara Gallucci, Bojana Lucic, Mahmoud M. Tolba, Liv Zimmermann, Julia M. Adler, Na Xing, Judith Bushe, Achim D. Gruber, Ina Ambiel, Ahmed Taha Ayoub, Mirko Cortese, Christopher J. Neufeldt, Bettina Stolp, Mohamed Hossam Sobhy, Moustafa Fathy, Min Zhao, Vibor Laketa, Ricardo Sobhie Diaz, Richard E. Sutton, Petr Chlanda, Steeve Boulant, Ralf Bartenschlager, Megan L. Stanifer, Oliver T. Fackler, Jakob Trimpert, Andrea Savarino & Marina Lusic. (2022) The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters . mBio 13:2.
Crossref
Md. Josim Uddin, Immacolata Faraone, Md. Anwarul Haque, Md. Mahbubur Rahman, Mohammad A. Halim, Frank D. Sönnichsen, Serhat Sezai Çiçek, Luigi Milella & Christian Zidorn. (2022) Insights into the leaves of Ceriscoides campanulata: Natural proanthocyanidins alleviate diabetes, inflammation, and esophageal squamous cell cancer via in vitro and in silico models. Fitoterapia 158, pages 105164.
Crossref
Olga Tarasova & Vladimir Poroikov. (2021) Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy. Current Medicinal Chemistry 28:38, pages 7840-7861.
Crossref
Sakshi Piplani, Puneet Kumar Singh, David A. Winkler & Nikolai Petrovsky. (2021) Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies. Molecular Biomedicine 2:1.
Crossref
Karen A. Gammeltoft, Yuyong Zhou, Carlos R. Duarte Hernandez, Andrea Galli, Anna Offersgaard, Rui Costa, Long V. Pham, Ulrik Fahnøe, Shan Feng, Troels K. H. Scheel, Santseharay Ramirez, Jens Bukh & Judith M. Gottwein. (2021) Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro . Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Md Afjalus Siraj, Md. Rahman, Ghee Tan & Veronique Seidel. (2021) Molecular Docking and Molecular Dynamics Simulation Studies of Triterpenes from Vernonia patula with the Cannabinoid Type 1 Receptor. International Journal of Molecular Sciences 22:7, pages 3595.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.